DK1307241T3 - Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension - Google Patents

Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension

Info

Publication number
DK1307241T3
DK1307241T3 DK01957701T DK01957701T DK1307241T3 DK 1307241 T3 DK1307241 T3 DK 1307241T3 DK 01957701 T DK01957701 T DK 01957701T DK 01957701 T DK01957701 T DK 01957701T DK 1307241 T3 DK1307241 T3 DK 1307241T3
Authority
DK
Denmark
Prior art keywords
irradiation
photodynamic treatment
thrombocyte suspension
thrombocyte
suspension
Prior art date
Application number
DK01957701T
Other languages
Danish (da)
English (en)
Inventor
Anette Redecker-Klein
Harald Mohr
Original Assignee
Blutspendedienst Dt Rote Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Dt Rote Kreuz filed Critical Blutspendedienst Dt Rote Kreuz
Application granted granted Critical
Publication of DK1307241T3 publication Critical patent/DK1307241T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215Disinfecting agents, e.g. antimicrobials for preserving living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0278Physical preservation processes
    • A01N1/0294Electromagnetic, i.e. using electromagnetic radiation or electromagnetic fields
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electromagnetism (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01957701T 2000-07-04 2001-07-04 Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension DK1307241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031851A DE10031851B4 (de) 2000-07-04 2000-07-04 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
PCT/DE2001/002410 WO2002002152A1 (fr) 2000-07-04 2001-07-04 Traitement photodynamique et exposition aux rayons u.v.-b d'une suspension de thrombocytes

Publications (1)

Publication Number Publication Date
DK1307241T3 true DK1307241T3 (da) 2005-08-08

Family

ID=7647321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01957701T DK1307241T3 (da) 2000-07-04 2001-07-04 Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension

Country Status (19)

Country Link
US (1) US20040072139A1 (fr)
EP (1) EP1307241B1 (fr)
CN (1) CN1264577C (fr)
AT (1) ATE296118T1 (fr)
AU (2) AU7955601A (fr)
BR (1) BR0111958A (fr)
CA (1) CA2415063C (fr)
CZ (1) CZ300018B6 (fr)
DE (2) DE10031851B4 (fr)
DK (1) DK1307241T3 (fr)
EA (1) EA004246B1 (fr)
ES (1) ES2241850T3 (fr)
HU (1) HU226418B1 (fr)
MX (1) MXPA02012663A (fr)
PL (1) PL363076A1 (fr)
PT (1) PT1307241E (fr)
SK (1) SK1002003A3 (fr)
WO (1) WO2002002152A1 (fr)
ZA (1) ZA200300257B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
JP4704684B2 (ja) * 2002-02-01 2011-06-15 カリディアンビーシーティ バイオテクノロジーズ,エルエルシー 光増感剤および光のピーク波長を使用する血液および血液製剤中の汚染の減少
EP1496114A1 (fr) * 2003-07-07 2005-01-12 Margraf, Stefan, Dr.med. Procédé d'inactivation de microorganismes
DE102010017687A1 (de) * 2010-07-01 2012-01-05 Claas Selbstfahrende Erntemaschinen Gmbh Verfahren zur Einstellung zumindest eines Arbeitsorganes einer selbstfahrenden Erntemaschine
CN109966574A (zh) * 2016-02-02 2019-07-05 汪相伯 一种基于核黄素光化学法的血液制品处理系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US6348309B1 (en) * 1989-09-13 2002-02-19 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. Process for inactivating viruses in blood and blood products
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
CA2199372A1 (fr) * 1994-09-22 1996-03-28 Raymond P. Goodrich, Jr. Procede d'inactivation photodynamique de contaminants du sang de nature virale et bacterienne a l'aide de sensibilisants a la coumarine ou la furocoumarine
EP0840624B1 (fr) * 1995-07-14 2007-07-25 CAF - DCF cvba - scrl Installation d'inactivation de contaminants viraux presents dans des produits sanguins
US20010053547A1 (en) * 1995-12-04 2001-12-20 Slichter Sherrill J. Method for preparing a platelet composition
EP0973383A4 (fr) * 1997-01-21 2001-08-22 American Nat Red Cross Decontamination intracellulaire et extracellulaire de sang total et de composants du sang au moyen de colorants amphiphiles phenotiazin-5-ium et de lumiere
US6258577B1 (en) * 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers

Also Published As

Publication number Publication date
HUP0301717A2 (hu) 2003-08-28
EA004246B1 (ru) 2004-02-26
HUP0301717A3 (en) 2005-12-28
CN1264577C (zh) 2006-07-19
EA200300111A1 (ru) 2003-06-26
US20040072139A1 (en) 2004-04-15
BR0111958A (pt) 2003-07-01
EP1307241A1 (fr) 2003-05-07
ES2241850T3 (es) 2005-11-01
CA2415063A1 (fr) 2002-12-30
DE10031851B4 (de) 2005-10-13
AU2001279556B2 (en) 2006-07-06
SK1002003A3 (en) 2003-06-03
EP1307241B1 (fr) 2005-05-25
ATE296118T1 (de) 2005-06-15
AU7955601A (en) 2002-01-14
CZ300018B6 (cs) 2009-01-14
HU226418B1 (en) 2008-12-29
WO2002002152A1 (fr) 2002-01-10
PT1307241E (pt) 2005-08-31
CN1440297A (zh) 2003-09-03
MXPA02012663A (es) 2004-07-30
DE50106329D1 (de) 2005-06-30
DE10031851A1 (de) 2002-01-24
ZA200300257B (en) 2003-11-04
CA2415063C (fr) 2006-10-03
PL363076A1 (en) 2004-11-15
CZ200315A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
CY1122841T1 (el) Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων
CO4970820A1 (es) Sal de bisulfato del inhibidor de la vih-proteasa
CY1105266T1 (el) Αποστειρωση γλυκοκορτικοστepοειδων εναιωρηματων
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
CY1117951T1 (el) Αναστολεiς κινασης υποκατεστημενης τριαζινης
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
CY1108845T1 (el) Συνδυασμοι οι οποιοι περιεχουν εναν αντιδιαρροϊκο παραγοντα και μια εποθιλονη ή ενα παραγωγο εποθιλονης
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
DK1459750T3 (da) (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
ATE430742T1 (de) Pyrimidinamine als angiogenesemodulatoren
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DK0431129T3 (da) Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
ATE451921T1 (de) Phenylindole zur behandlung von hiv
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
DK1307241T3 (da) Fotodynamisk behandling og UV-B-bestråling af en thrombozytsuspension
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DE69005464D1 (de) Biozide Mittel und Behandlungsverfahren.
YU33795A (sh) Smese koncentrata suspenzija insekti-cidnih i akaricidnih sredstava arilpirola
CY1105671T1 (el) Μεθοδος δια την απενεργοποιηση βακτηριδιων και λευκοκυτταρων εις εναιωρηματα θρομβοκυτταρων
DK0768886T3 (da) Endothelforingseffekter og behandling af vasospastiske lidelser
IT1278056B1 (it) Derivati della s-triazina, loro preparazione e loro impiego come assorbenti uv.
DE60200302D1 (de) Laseraugenbehandlungseinrichtung
ATE230718T1 (de) Beta-alkoxyacrylate gegen malaria